Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Stock price
Equities
2315
CNE100005D27
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 12.02 CNY | -1.15% | -6.97% | -53.14% | |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Sales 2023 * | 727 M 102 M | Sales 2024 * | 974 M 136 M | Capitalization | 4,387 M 615 M |
|---|---|---|---|---|---|
| Net income 2023 * | -354 M -49.61 M | Net income 2024 * | -109 M -15.28 M | EV / Sales 2023 * | 6,23x |
| Net Debt 2023 * | 139 M 19.55 M | Net Debt 2024 * | 128 M 17.92 M | EV / Sales 2024 * | 4,64x |
| P/E ratio 2023 * | -12,3x | P/E ratio 2024 * | -40,7x | Employees | 1,313 |
| Yield 2023 * | - | Yield 2024 * | - | Free-Float | 16.99% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.15% | ||
| 1 week | -6.97% | ||
| Current month | +1.18% | ||
| 1 month | +1.86% | ||
| 3 months | -26.53% | ||
| 6 months | -49.81% | ||
| Current year | -53.14% |
1 week
11.80
13.10
1 month
11.3013.50
Current year
10.9227.80
1 year
10.9227.80
3 years
10.9228.80
5 years
10.9228.80
10 years
10.9228.80
| Managers | Title | Age | Since |
|---|---|---|---|
Yue Lei Shen
CEO | Chief Executive Officer | - | 2009 |
Liu Bin
DFI | Director of Finance/CFO | - | 2020 |
Sabrina Wang
COO | Chief Operating Officer | - | 2019 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Feng Mao Hua
BRD | Director/Board Member | 55 | 2021 |
Yi Liang Wei
BRD | Director/Board Member | 52 | - |
Xiao Yan Liang
BRD | Director/Board Member | 57 | 2020 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-11-29 | 12.02 | -1.15% | 200 500 |
| 23-11-29 | 12.16 | +2.01% | 176,000 |
| 23-11-28 | 11.92 | -4.49% | 634,500 |
| 23-11-27 | 12.48 | -2.95% | 205,000 |
| 23-11-24 | 12.86 | -1.83% | 167,000 |
End-of-day quote Hong Kong Stock Exchange, November 29, 2023
More quotes
Biocytogen Pharmaceuticals Beijing Co Ltd is a China-based company mainly engaged in drug development business and preclinical research. The Company operates two business segments. The Drug Development Business segment is mainly engaged in the research and development of oncology and autoimmune disease treatments, as well as antibody development. The Preclinical Research Service segment is mainly engaged in gene editing, preclinical pharmacological efficacy evaluation and model animal sales.
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.98CNY
Average target price
19.74CNY
Spread / Average Target
+79.76%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -53.14% | 622 M $ | |
| +65.70% | 40 283 M $ | |
| +3.94% | 39 020 M $ | |
| -56.39% | 30 125 M $ | |
| -25.31% | 28 999 M $ | |
| +37.57% | 21 980 M $ | |
| -29.45% | 20 582 M $ | |
| +1.50% | 17 372 M $ | |
| -13.83% | 10 906 M $ | |
| -9.35% | 10 111 M $ |
